[en] Studies of lysozyme have played a major role over several decades in defining the general principles underlying protein structure, folding, and stability. Following the discovery some 10 years ago that two mutational variants of lysozyme are associated with systemic amyloidosis, these studies have been extended to investigate the mechanism of amyloid fibril formation. This Account describes our present knowledge of lysozyme folding and misfolding, and how the latter can give rise to amyloid disease. It also discusses the significance of these studies for our general understanding of normal and aberrant protein folding in the context of human health and disease.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Dumoulin, Mireille ; Université de Liège - ULiège > Département des sciences de la vie > Enzymologie et repliement des protéines
Kumita, Janet
Dobson, Christopher M
Language :
English
Title :
Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants
Pepys, M. B.; Hawkins, P. N.; Booth, D. R.; Vigushin, D. M.; Tennent, G. A.; Soutar, A. K.; Totty, N.; Nguyen, O.; Blake, C. C. F.; Terry, C. J.; Feest, T. G.; Zalin, A. M.; Hsuan, J. J. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993, 362, 553-557.
Valleix, S.; Drunat, S.; Philit, J. B.; Adoue, D.; Piette, J. C.; Droz, D.; MacGregor, B.; Canet, D.; Delpech, M.; Grateau, G. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int. 2002, 61, 907-912.
Yazaki, M.; Farrell, S. A.; Benson, M. D. A novel lysozyme mutation Phe57lle associated with hereditary renal amyloidosis. Kidney Int. 2003, 63, 1652-1657.
Rocken, C.; Becker, K.; Fandrich, M.; Schroeckh, V.; Stix, B.; Rath, T.; Kahne, T.; Dierkes, J.; Roessner, A.; Albert, F. W. ALys amyloidosis caused by compound heterozygosity in Exon 2 (Thr70Asn) and Exon 4 (Trp112Arg) of the lysozyme gene. Hum. Mutat. 2005, 27, 119-120.
Booth, D. R.; Pepys, M. B.; Hawkins, P. N. A novel variant of human lysozyme (T70N) is common in the normal population. Hum. Mutat. 2000, 16, 180.
Dumoulin, M.; Bellotti, V.; Dobson, C. M. Hereditary systemic amyloidosis associated with mutational variants of human lysozyme. In The beta pleated sheet conformation and disease; Sipe, J. D., Ed.; VCH Verlag GmbH & Co KgaA publisher: Weinheim, Germany, 2005; pp 635-656.
Dumoulin, M.; Johnson, R. J. K.; Belotti, V.; Dobson, C. M. Human lysozyme. In Protein misfolding, aggregation and conformational diseases. II. Molecular basis of conformational diseases; Fink, A. L., Ed.; Kluwer Academic: Dordrecht, The Netherlands, 2006; Vol. II; in press.
Booth, D. R.; Sunde, M.; Bellotti, V.; Robinson, C. V.; Hutchinson, W. L.; Fraser, P. E.; Hawkins, P. N.; Dobson, C. M.; Radford, S. E.; Blake, C. C. F.; Pepys, M. B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997, 385, 787-793.
Johnson, J. R. K.; Christodoulou, J.; Dumoulin, M.; Caddy, G.; Alcocer, M. J.; Murtagh, G. J.; Kumita, J. R.; Larsson, G.; Robinson, C. V.; Archer, D. B.; Luisi, B.; Dobson, C. M. Rationalising lysozyme amyloidosis: Insight from the structure and solution dynamics of T70N lysozyme. J. Mol. Biol. 2005, 352, 823-836.
Esposito, G.; Garcia, J.; Mangione, P.; Giorgetti, S.; Corazza, A.; Viglino, P.; Chili, F.; Andreola, A.; Dumy, P.; Booth, D.; Hawkins, P. N.; Bellotti, V. Structural and folding dynamics properties of T70N variant of human lysozyme. J. Biol. Chem. 2003, 278, 25910-25918.
Wain, R.; Smith, L. J.; Dobson, C. M. Oxidative refolding of amyloidogenic variants of human lysozyme. J. Mol. Biol. 2005, 351, 662-671.
Canet, D.; Sunde, M.; Last, A. M.; Miranker, A.; Spencer, A.; Robinson, C. V.; Dobson, C. M. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. Biochemistry 1999, 38, 6419-6427.
Hooke, S. D.; Radford, S. E.; Dobson, C. M. The refolding of human lysozyme: a comparison with the structurally homologous hen lysozyme. Biochemistry 1994, 33, 5867-5876.
Dobson, C. M.; Evans, P. A.; Radford, S. E. Understanding how proteins fold: the lysozyme story so far. Trends Biochem. Sci. 1994, 19, 31-37.
Dinner, A. R.; Sali, A.; Smith, L. J.; Dobson, C. M.; Karplus, M. Understanding protein folding via free-energy surfaces from theory and experiment. Trends Biochem. Sci. 2000, 25, 331-339.
Dumoulin, M.; Canet, D.; Last, A. M.; Pardon, E.; Archer, D. B.; Muyldermans, S.; Wyns, L.; Matagne, A.; Robinson, C. V.; Redfield, C.; Dobson, C. M. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J. Mol. Biol. 2005, 346, 773-788.
Kumita, J. R.; Johnson, J. R. K.; Alcocer, M. J.; Dumoulin, M.; Holinquist, F.; McCammon, M. G.; Robinson, C. V.; Archer, D. B.; Dobson, C. M. Expression of the amyloidogenic human lysozyme variants F57I and W64R in Pichia pastoris: Impact of native state stability on protein secretion levels. FEBS J. 2006, 273, 711-720.
Morozova-Roche, L. A.; Zurdo, J.; Spencer, A.; Noppe, W.; Receveur, V.; Archer, D. B.; Joniau, M.; Dobson, C. M. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 2000, 130 339-351.
Canet, D.; Last, A. M.; Tito, P.; Sunde, M.; Spencer, A.; Archer, D. B.; Redfield, C.; Robinson, C. V.; Dobson, C. M. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat. Struct. Biol. 2002, 9, 308-315.
Frare, E.; Polverino de Laureto, P.; Zurdo, J.; Dobson, C. M.; Fontana, A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 2004, 340, 1153-1165.
Pawar, A. P.; Dubay, K. F.; Zurdo, J.; Chiti, F.; Vendruscolo, M.; Dobson, C. M. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 2005, 350, 379-392.
Dumoulin, M.; Conrath, K.; Van Meirhaeghe, A.; Meersman, F.; Heremans, K.; Frenken, L. G.; Muyldermans, S.; Wyns, L.; Matagne, A. Single-domain antibody fragments with high conformational stability. Protein Sci. 2002, 11, 500-515.
Dumoulin, M.; Last, A. M.; Desmyter, A.; Decanniere, K.; Canet, D.; Larsson, G.; Spencer, A.; Archer, D. B.; Sasse, J.; Muyldermans, S.; Wyns, L.; Redfield, C.; Matagne, A.; Robinson, C. V.; Dobson, C. M. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 2003, 424, 783-788.
Dobson, C. M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 1999, 24, 329-332.
Guijarro, J. I.; Sunde, M.; Jones, J. A.; Campbell, I. D.; Dobson, C. M. Amyloid fibril formation by an SH3 domain. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4224-4228.
Litvinovich, S. V.; Brew, S. A.; Aota, S.; Akiyama, S. K.; Haudenschild, C.; Ingham, K. C. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol. 1998, 280, 245-258.
Stefani, M.; Dobson, C. M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 2003, 81, 678-699.
Dobson, C. M. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 2004, 15, 3-16.
Branden, C.; Tooze, J. Introduction to protein structure, 2nd ed.; Garland Publishing: New York, 1999.
Jaroniec, C. P.; MacPhee, C. E.; Bajaj, V. S.; McMahon, M. T.; Dobson, C. M.; Griffin, R. G. High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 711-716.
Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. O.; Riekel, C.; Grothe, R.; Eisenberg, D. Structure of the cross-beta spine of amyloid-like fibrils. Nature 2005, 435, 773-778.
Krebs, M. R.; Morozova-Roche, L. A.; Daniel, K.; Robinson, C. V.; Dobson, C. M. Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci. 2004, 13, 1933-1938.
Fandrich, M.; Dobson, C. M. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J. 2002, 21, 5682-5690.
Dobson, C. M. Getting out of shape. Nature 2002, 418, 729-730.
Gillmore, J. D.; Booth, D. R.; Madhoo, S.; Pepys, M. B.; Hawkins, P. N. Hereditary renal amyloidosis associated with variant lysozyme in a large English family. Nephrol., Dial., Transplant. 1999, 14, 2639-2644.
Vendruscolo, M.; Paci, E.; Karplus, M.; Dobson, C. M. Structures and relative free energies of partially folded states of proteins. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 14817-14821.
Dumoulin, M.; Dobson, C. M. Probing the origins, diagnosis and treatment of amyloid diseases using antibodies. Biochimie 2004, 86, 589-600.